Understanding PrEP Acceptability Among Priority Populations: Results from a Qualitative Study of Potential Users in Central Uganda

被引:0
作者
Radhika Sundararajan
Monique A. Wyatt
Timothy R. Muwonge
Emily E. Pisarski
Andrew Mujugira
Jessica E. Haberer
Norma C. Ware
机构
[1] Weill Cornell Medicine,Center for Global Health
[2] Weill Cornell Medicine,Department of Emergency Medicine
[3] Harvard Medical School,Department of Global Health and Social Medicine
[4] Harvard Global,Department of Medicine
[5] Infectious Diseases Institute,Department of Medicine
[6] Massachusetts General Hospital,undefined
[7] Brigham and Women’s Hospital,undefined
来源
AIDS and Behavior | 2022年 / 26卷
关键词
Pre-exposure prophylaxis; Uganda; HIV prevention; Priority populations; Scale-up;
D O I
暂无
中图分类号
学科分类号
摘要
Daily oral pre-exposure prophylaxis (PrEP) can safely and effectively prevent HIV acquisition in HIV-negative individuals. However, uptake of PrEP has been suboptimal in sub-Saharan Africa. The goal of this qualitative study was to identify facilitators of and barriers to PrEP acceptability among target users not taking PrEP. Fifty-nine individuals belonging to Ugandan priority populations participated in a single in-depth interview. Participants perceived themselves as being at high risk for HIV acquisition, and expressed interest in PrEP as an HIV prevention strategy. Two forms of stigma emerged as potential barriers to PrEP use: (1) misidentification as living with HIV; and (2) disclosure of membership in a priority population. Acceptability of PrEP was dampened for this sample of potential PrEP users due to anticipated stigmatization. Mitigating stigma should be a key component of effective PrEP delivery to reach UNAIDS goal of ending the AIDS epidemic by 2030.
引用
收藏
页码:2676 / 2685
页数:9
相关论文
共 283 条
[1]  
Baeten JM(2012)Antiretroviral prophylaxis for HIV prevention in heterosexual men and women N Engl J Med 367 399-410
[2]  
Donnell D(2012)Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 423-434
[3]  
Ndase P(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-2599
[4]  
Mugo NR(2016)Effectiveness and safety of oral HIV preexposure prophylaxis for all populations AIDS 30 1973-1983
[5]  
Campbell JD(2016)Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1-serodiscordant couples: a prospective implementation study in Kenya and Uganda PLoS Med 13 e1002099-48
[6]  
Wangisi J(2019)Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya PLoS Med 16 e1002885-28
[7]  
Thigpen MC(2020)Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa PLoS ONE 15 e0228620-e48
[8]  
Kebaabetswe PM(2020)Pharmacy delivery to expand the reach of PrEP in Africa J Int AIDS Soc 23 e25619-468
[9]  
Paxton LA(2020)Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries J Int AIDS Soc 23 e25451-265
[10]  
Smith DK(2016)HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities Open AIDS J. 10 34-2172